GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Financial Strength

Mesa Laboratories (Mesa Laboratories) Financial Strength : 5 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Financial Strength?

Mesa Laboratories has the Financial Strength Rank of 5.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Mesa Laboratories did not have earnings to cover the interest expense. Mesa Laboratories's debt to revenue ratio for the quarter that ended in Dec. 2023 was 1.10. As of today, Mesa Laboratories's Altman Z-Score is 1.57.


Competitive Comparison of Mesa Laboratories's Financial Strength

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's Financial Strength Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Financial Strength distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Financial Strength falls into.



Mesa Laboratories Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Mesa Laboratories's Interest Expense for the months ended in Dec. 2023 was $-1.9 Mil. Its Operating Income for the months ended in Dec. 2023 was $-0.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $233.0 Mil.

Mesa Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is

Mesa Laboratories did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Mesa Laboratories's Debt to Revenue Ratio for the quarter that ended in Dec. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.135 + 232.965) / 213.892
=1.10

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Mesa Laboratories has a Z-score of 1.57, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of 1.57 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesa Laboratories  (NAS:MLAB) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Mesa Laboratories has the Financial Strength Rank of 5.


Mesa Laboratories Financial Strength Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines

From GuruFocus

MESA LABS DECLARES QUARTERLY DIVIDEND

By GuruFocusNews GuruFocusNews 07-06-2022

Mesa Labs Announces First Quarter Results

By Marketwired Marketwired 08-05-2021

Mesa Labs Announces First Quarter Results

By Marketwired 08-03-2023

Mesa Labs Acquires Belyntic's Peptide Purification Business

By Value_Insider Value_Insider 11-17-2022

MESA LABS DECLARES QUARTERLY DIVIDEND

By Marketwired 10-03-2023

Mesa Labs Declares Quarterly Dividend

By Stock market mentor Stock market mentor 01-03-2023

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

By GuruFocusNews GuruFocusNews 07-07-2022

MESA LABS DECLARES QUARTERLY DIVIDEND

By Marketwired 07-05-2023